Monitoring Continuous Glucose and Physical Activity Using Wearable Devices to Improve Cardiovascular Risk After Cardiac Rehabilitation A Randomized Controlled Study

What this Trial Is About

This research aims to evaluate how wearing smart watches and continuous glucose monitoring devices affects cardiovascular risk factors in patients with coronary heart disease who have completed cardiac rehabilitation. The study will recruit 100 patients, randomly assigning them to either an intervention group or a control group for three months. Researchers will look at changes in factors like blood pressure, cholesterol LDL, blood sugar control HbA1c, body mass index BMI, physical activity, nutrition, and smoking habits. Participants in the intervention group will receive a Fitbit Inspire 2 smart watch and an Abbott Freestyle Libre 3 continuous glucose monitor, which they will wear for three months. The control group will receive standard care recommendations typical for patients finishing cardiac rehabilitation. Randomization will consider age, sex, BMI, diabetes status, blood pressure, and time since rehabilitation completion. Data on sleep, temperature, heart rate, breathing rate, activity, oxygen levels, and weight will be collected through the Fitbit app. During the study, all participants will complete questionnaires and have physical measurements taken at the start and end of the study. Blood samples will also be collected at these times. The researchers will monitor cardiovascular risk scores using multiple measurements over the three months. The total participation time is about four months, including recruitment and study duration. The study is sponsored by University Hospital, Basel, Switzerland, and aims to better understand how wearable technology might influence heart health after rehabilitation.

Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors